glp 1 vs sglt2 weight loss Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity | Drugs Effect of combination treatment with
Description
The images were uniformly amended with minimal Gaussian blur to reduce graininess
Mizuno K, Antunes-Martins A, Ris L, Peters M, Godaux E, Giese KP
Setting realistic expectations is crucial: weight loss is gradual, with clinical trials showing approximately 15% weight reduction with semaglutide 2.4 mg at 68 weeks and up to 21% with tirzepatide at 72 weeks, though individual responses vary considerably
Ziyad Al-Aly, chief of research and development at the VA St
Yet only 12% of GLP-1 users receive supplement guidance from their healthcare provider
